ArticleOncotarget2016

Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of Kv1.3 channels and T cell responsiveness.

Theresa Lowinus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.